ArticleFrontiers in immunology2022

Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Unresectable Hepatocellular Carcinoma: Efficacy and Systemic Immune Response.

Fei Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.